Zarogoulidis, P., Chinelis, P., Efthymiou, C., Athanasiadou, A., Mpikos, V., Papatsibas, G., . . . Hohenforst-Schmidt, W. (2017). EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50%. Respir Med Case Rep.
Citação norma ChicagoZarogoulidis, Paul, et al. "EGFR or PD-L1 Decision for First Line Therapy in a Case Series of EGFR Positive and PD-L1 >50%." Respir Med Case Rep 2017.
MLA citiranjeZarogoulidis, Paul, et al. "EGFR or PD-L1 Decision for First Line Therapy in a Case Series of EGFR Positive and PD-L1 >50%." Respir Med Case Rep 2017.
Opozorilo: Ti citati niso vedno 100% točni.